COLIN MORGAN: Open Payments
NPI 1194110502 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,249 in 190 payments from 21 companies in 2025. Trend: 2023 $2,854 · 2024 $3,129 · 2025 $3,249
Food & beverage: $3,249
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $469 |
| ABBVIE INC. | 32 | $320 |
| PFIZER INC. | 19 | $286 |
| Novo Nordisk Inc | 12 | $241 |
| Corium, LLC | 14 | $229 |
| Axsome Therapeutics, Inc. | 10 | $222 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $173 |
| GlaxoSmithKline, LLC. | 13 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $144 |
| Amgen Inc. | 10 | $136 |
Products named: Azstarys, NURTEC ODT, Auvelity, AIRSUPRA, CAPLYTA, VRAYLAR, Kerendia, BREZTRI.
Industry payments across OK — which companies pay providers there.
